155 related articles for article (PubMed ID: 7854995)
1. [Effect of cetirizine therapy on the rate of adverse reactions to specific desensitization].
Kruszewski J; Zaraś E
Pol Tyg Lek; 1994 Apr 4-11; 49(14-15):337-40. PubMed ID: 7854995
[TBL] [Abstract][Full Text] [Related]
2. [Multicenter drug surveillance of sublingual immunotherapy in allergic patients].
Almagro E; Asensio O; Bartolomé JM; Bosque M; de la Hoz B; Dolz I; Elorza J; Ferreiro M; García JM; Losada E
Allergol Immunopathol (Madr); 1995; 23(4):153-9. PubMed ID: 8553989
[TBL] [Abstract][Full Text] [Related]
3. [Specific hyposensitization in allergies of the immediate type. Indications, implementation, side effects and preventive measures].
Kleber R; Gall H
Fortschr Med; 1987 Mar; 105(8):139-42. PubMed ID: 3583196
[No Abstract] [Full Text] [Related]
4. [Real effect of specific hyposensitisation in therapy of allergic respiratory diseases].
Plavsić Z; Petrović M; Popovac D
Srp Arh Celok Lek; 1994; 122(7-8):210-1. PubMed ID: 17974388
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
[TBL] [Abstract][Full Text] [Related]
6. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child.
Pediatr Allergy Immunol; 1998 Aug; 9(3):116-24. PubMed ID: 9814724
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy.
Müller UR; Jutel M; Reimers A; Zumkehr J; Huber C; Kriegel C; Steiner U; Haeberli G; Akdis M; Helbling A; Schnyder B; Blaser K; Akdis C
J Allergy Clin Immunol; 2008 Nov; 122(5):1001-1007.e4. PubMed ID: 18845330
[TBL] [Abstract][Full Text] [Related]
9. [Practical problems in specific hyposensitization].
Oehling A
Med Klin; 1972 Jul; 67(29):983-8. PubMed ID: 5051382
[No Abstract] [Full Text] [Related]
10. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up.
Warner JO;
J Allergy Clin Immunol; 2001 Dec; 108(6):929-37. PubMed ID: 11742270
[TBL] [Abstract][Full Text] [Related]
11. Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis.
Galli E; Chini L; Nardi S; Benincori N; Panei P; Fraioli G; Moschese V; Rossi P
Allergol Immunopathol (Madr); 1994; 22(1):18-22. PubMed ID: 8030579
[TBL] [Abstract][Full Text] [Related]
12. Safety of specific immunotherapy: a retrospective study.
Luigi A; Senna G; Mezzelani P; Pappalardo G
J Investig Allergol Clin Immunol; 1994; 4(5):250-4. PubMed ID: 7874322
[TBL] [Abstract][Full Text] [Related]
13. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus.
Tabar AI; Echechipía S; García BE; Olaguibel JM; Lizaso MT; Gómez B; Aldunate MT; Martin S; Marcotegui F
J Allergy Clin Immunol; 2005 Jul; 116(1):109-18. PubMed ID: 15990782
[TBL] [Abstract][Full Text] [Related]
14. [Specific immunotherapy in desensitization of allergic patients. Oral administration instead of injections? (interview by Andrea Warpakowski)].
Grevers G
MMW Fortschr Med; 2003 May; 145(18):18. PubMed ID: 12808815
[No Abstract] [Full Text] [Related]
15. Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.
Broome CB; Schiff RI; Friedman HS
Med Pediatr Oncol; 1996 Feb; 26(2):105-10. PubMed ID: 8531847
[TBL] [Abstract][Full Text] [Related]
16. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
17. [Incorrect treatment of patients with allergic disorders].
Gniazdowski R
Wiad Lek; 1986 Feb; 39(4):275-82. PubMed ID: 3088844
[No Abstract] [Full Text] [Related]
18. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
[TBL] [Abstract][Full Text] [Related]
19. Side-effects of allergen-specific immunotherapy: a prospective multi-centre study.
Winther L; Arnved J; Malling HJ; Nolte H; Mosbech H
Clin Exp Allergy; 2006 Mar; 36(3):254-60. PubMed ID: 16499635
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and its persistence, in children and adults.
Di Rienzo V
Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):35-7. PubMed ID: 17761106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
